FR2809727B1 - Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations - Google Patents

Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations

Info

Publication number
FR2809727B1
FR2809727B1 FR0007029A FR0007029A FR2809727B1 FR 2809727 B1 FR2809727 B1 FR 2809727B1 FR 0007029 A FR0007029 A FR 0007029A FR 0007029 A FR0007029 A FR 0007029A FR 2809727 B1 FR2809727 B1 FR 2809727B1
Authority
FR
France
Prior art keywords
pharmaceutical
novel
compositions containing
cosmetic compositions
aminothiolester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0007029A
Other languages
English (en)
French (fr)
Other versions
FR2809727A1 (fr
Inventor
Guy Fournet
Georges Anthony Quash
Jacques Gore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to FR0007029A priority Critical patent/FR2809727B1/fr
Priority to ARP010102577A priority patent/AR028122A1/es
Priority to DE60102925T priority patent/DE60102925T2/de
Priority to EP01940654A priority patent/EP1296946B1/fr
Priority to AT01940654T priority patent/ATE264839T1/de
Priority to JP2002500835A priority patent/JP4855626B2/ja
Priority to PCT/FR2001/001694 priority patent/WO2001092220A1/fr
Priority to AU2001274171A priority patent/AU2001274171A1/en
Priority to US10/296,927 priority patent/US7078402B2/en
Priority to ES01940654T priority patent/ES2219530T3/es
Publication of FR2809727A1 publication Critical patent/FR2809727A1/fr
Application granted granted Critical
Publication of FR2809727B1 publication Critical patent/FR2809727B1/fr
Priority to US11/390,480 priority patent/US8026231B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/22—Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR0007029A 2000-05-31 2000-05-31 Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations Expired - Fee Related FR2809727B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR0007029A FR2809727B1 (fr) 2000-05-31 2000-05-31 Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations
ARP010102577A AR028122A1 (es) 2000-05-31 2001-05-30 Nuevos compuestos aminotiolésteres, composiciones farmacéuticas y cosméticas que los contienen y utilizaciones
ES01940654T ES2219530T3 (es) 2000-05-31 2001-05-31 Compuestos aminotiolesteres, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
AT01940654T ATE264839T1 (de) 2000-05-31 2001-05-31 Amino-thiolester-verbindungen, diese enthaltende pharmazeutische und kosmetische zusammensetzungen und ihre anwendungen
JP2002500835A JP4855626B2 (ja) 2000-05-31 2001-05-31 製薬分野における新規なアミノチオールエステル誘導体
PCT/FR2001/001694 WO2001092220A1 (fr) 2000-05-31 2001-05-31 Composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations
DE60102925T DE60102925T2 (de) 2000-05-31 2001-05-31 Amino-thiolester-verbindungen, diese enthaltende pharmazeutische und kosmetische zusammensetzungen und ihre anwendungen
US10/296,927 US7078402B2 (en) 2000-05-31 2001-05-31 Aminothiol ester compounds, pharmaceutical and cosmetics compositions containing same and uses thereof
EP01940654A EP1296946B1 (fr) 2000-05-31 2001-05-31 Composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations
AU2001274171A AU2001274171A1 (en) 2000-05-31 2001-05-31 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
US11/390,480 US8026231B2 (en) 2000-05-31 2006-03-28 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0007029A FR2809727B1 (fr) 2000-05-31 2000-05-31 Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations

Publications (2)

Publication Number Publication Date
FR2809727A1 FR2809727A1 (fr) 2001-12-07
FR2809727B1 true FR2809727B1 (fr) 2002-07-26

Family

ID=8850863

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0007029A Expired - Fee Related FR2809727B1 (fr) 2000-05-31 2000-05-31 Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations

Country Status (10)

Country Link
US (1) US8026231B2 (enExample)
EP (1) EP1296946B1 (enExample)
JP (1) JP4855626B2 (enExample)
AR (1) AR028122A1 (enExample)
AT (1) ATE264839T1 (enExample)
AU (1) AU2001274171A1 (enExample)
DE (1) DE60102925T2 (enExample)
ES (1) ES2219530T3 (enExample)
FR (1) FR2809727B1 (enExample)
WO (1) WO2001092220A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2983492B1 (fr) * 2011-12-06 2015-10-30 Advanced Biodesign Procede ex vivo de purge tumorale d'un echantillon biologique
PL3362094T3 (pl) * 2015-10-15 2021-10-11 Advanced Biodesign Kombinacja zawierająca związek tioaminoestrowy lub jego farmaceutycznie dopuszczalną sól oraz związek mogący zwiększyć poziom h2o2 w komórkach nowotworowych osobnika
LT3362056T (lt) 2015-10-15 2021-05-10 Advanced Biodesign Aminotiolesterio junginiai arba jų farmaciniu požiūriu priimtinos druskos, skirti naudoti vėžio gydyme
FR3047734B1 (fr) * 2016-02-17 2019-09-06 Advanced Biodesign Procede de preparation de composes aminothiolester et leurs sels
US20220265845A1 (en) * 2019-07-31 2022-08-25 Advanced Biodesign Aminothiolester compounds and uses thereof
EP4035666A1 (en) 2021-01-29 2022-08-03 Advanced Biodesign Aminothiolester compound or derivative thereof for use as an immunomodulatory agent
FR3119314B1 (fr) 2021-01-29 2025-01-10 Advanced Biodesign Nanocapsule lipidique comprenant au moins un composé aminothiolester ou un de ses dérivés pharmaceutiquement acceptable
WO2025229179A1 (en) 2024-05-03 2025-11-06 Advanced Biodesign Use of aminothiolester compounds in combination with hypomethylating agents (hma) for the prevention and treatment of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051528A (en) * 1990-04-24 1991-09-24 Eastman Kodak Company Recovery process for ethylene glycol and dimethylterephthalate
JPH0797350A (ja) * 1993-08-02 1995-04-11 Mitsubishi Chem Corp ベンゾイルアセチレン誘導体
FR2761606B1 (fr) * 1997-04-08 1999-05-14 Cird Galderma Utilisation de derives aminothiolesters dans le domaine pharmaceutique
KR100488985B1 (ko) 1997-12-02 2005-05-11 하인리히 스무다 폴리에틸렌테레프탈레이트 폐기물로부터 테레프탈산 및 에틸렌글리콜을 회수하는 방법
FR2777001B1 (fr) * 1998-04-01 2000-06-09 Cird Galderma Derives de l'acide 6,8-dimercaptooctanoique substitues en 6-s et/ou en 8-s par le radical (3-methylthiopropanoyl) et compositions pharmaceutiques destinees au traitement des tumeurs cancereuses
EP1227075B1 (en) 1999-10-22 2009-07-29 Teijin Limited Method for separating and recovering dimethyl terephthalate and ethylene glycol from polyester waste
JP3808672B2 (ja) * 1999-11-26 2006-08-16 東洋製罐株式会社 回収ポリエチレンテレフタレート粉砕品からのテレフタル酸の工業的回収方法

Also Published As

Publication number Publication date
DE60102925T2 (de) 2005-04-07
FR2809727A1 (fr) 2001-12-07
DE60102925D1 (de) 2004-05-27
WO2001092220A1 (fr) 2001-12-06
JP4855626B2 (ja) 2012-01-18
JP2003535076A (ja) 2003-11-25
EP1296946B1 (fr) 2004-04-21
AU2001274171A1 (en) 2001-12-11
AR028122A1 (es) 2003-04-23
US20070032476A1 (en) 2007-02-08
ATE264839T1 (de) 2004-05-15
ES2219530T3 (es) 2004-12-01
EP1296946A1 (fr) 2003-04-02
US8026231B2 (en) 2011-09-27

Similar Documents

Publication Publication Date Title
EP1539730A4 (en) NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD FOR THEIR APPLICATION
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
FR2807038B1 (fr) Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant
MA26537A1 (fr) Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
MA26714A1 (fr) Composes nouveaux modulateurs de chimiokine ccr5 et compositions pharmaceutiques les contenant
FR2790473B1 (fr) Nouveaux composes et medicaments les contenant
MA26715A1 (fr) Composes chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
FR2810033B1 (fr) Nouveaux composes de la famille des n-acylamino-amides, compositions les comprenant, et utilisations
BR0115810B1 (pt) composições cosméticas, dermatológicas e farmacêuticas isentas de tensoativos.
FR2811552B1 (fr) Composition notamment cosmetique ou pharmaceutique se presentant sous forme solide
EE05183B1 (et) Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
FR2811992B1 (fr) Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
FR2823102B1 (fr) Produit de maquillage bicouche, ses utilisations et kit de maquillage contenant ce produit
MA26547A1 (fr) Composes nouveaux, antagonistes des recepteurs de vitronectine, et compositions pharmaceutiques les contenant.
EP1534263A4 (en) NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF ADMINISTRATION THEREFOR
FR2751969B1 (fr) Composes activateurs du canal cftr, et compositions pharmaceutiques les contenant
FR2796380B3 (fr) Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
FR2809727B1 (fr) Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations
FR2795315B1 (fr) Compositions cosmetiques contenant un polymere amphotere et un agent antipelliculaire et leurs utilisations
EP1482937A4 (en) NEW TYLOINDICINE AND RELATED METHOD, PHARMACEUTICAL COMPOSITIONS AND METHOD
FR2776659B1 (fr) Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant
FR2857971B1 (fr) Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
DZ3055A1 (fr) Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant.
FR2811562B1 (fr) Composition, notamment cosmetique, renfermant la dhea et un isoflavonoide

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 16

ST Notification of lapse

Effective date: 20170131